Thanks to increased awareness, technology adoption and improved access to information.
GlobalData said the diabetes care equipment market in India is expected to rise to 2033 at a compound annual growth rate of about 4%.
The industry's expansion is attributed to increased awareness, technology adoption and improved access to information.
In addition, the country accounts for 20% of the Asia-Pacific market in 2024. Diagnosis, increased disposable income and technological advancements contribute to this growth.
Meanwhile, artificial intelligence (AI)-driven solutions are expected to play a key role in diabetes management.
Shreya Jain, medical device analyst at GlobalData, said that AI’s ongoing AI research focuses on predictive glucose models, automated insulin delivery systems and risk assessment tools.
Jain added: “The field still faces key challenges related to the lack of transparency, personalization, and integration with existing systems that require innovative approaches to improve prediction accuracy and ensure effective implementation.”
